MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on Blue Medicare Rx Enhanced (S5540-004)

Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), North Carolina
Premium
$163.20/month
Deductible
None
Change plan

4 of 8 Multiple sclerosis drugs are covered on this plan. All 4 require prior authorization.

4 aren't on the formulary, including teriflunomide and Mayzent.

  • Kesimpta
    ofatumumab
    Covered · prior auth
    $16,047.74
    Tier 5
  • dimethyl fumarate
    generic Tecfidera
    Covered · prior auth
    from $44.56
    Tier 4
  • Vumerity
    diroximel fumarate
    Covered · prior auth
    $3,173.53
    Tier 5
  • fingolimod
    generic Gilenya
    Covered · prior auth
    $96.19
    Tier 4
Not on the formulary
teriflunomide, Mayzent, Zeposia, Mavenclad

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list